Navigating Clinical Development Challenges for Rare Disease Therapies
Rare diseases, as defined by the Orphan Drug Act (ODA), affect fewer than 200,000 people in the United States. Although […]
rare disease drug development challenges
Rare diseases, as defined by the Orphan Drug Act (ODA), affect fewer than 200,000 people in the United States. Although […]